• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2 Mid-Cap Stocks to Consider Right Now and 1 to Question

By: StockStory
June 17, 2025 at 00:37 AM EDT

DRS Cover Image

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are two mid-cap stocks with massive growth potential and one that may have trouble.

One Mid-Cap Stock to Sell:

Zimmer Biomet (ZBH)

Market Cap: $18.23 billion

With a history dating back to 1927 and a presence in over 100 countries worldwide, Zimmer Biomet (NYSE: ZBH) designs and manufactures orthopedic products including knee and hip replacements, surgical tools, and robotic technologies for joint reconstruction and spine surgeries.

Why Does ZBH Worry Us?

  1. Flat sales over the last five years suggest it must find different ways to grow during this cycle
  2. Constant currency growth was below our standards over the past two years, suggesting it might need to invest in product improvements to get back on track
  3. Below-average returns on capital indicate management struggled to find compelling investment opportunities

At $92.75 per share, Zimmer Biomet trades at 11.1x forward P/E. To fully understand why you should be careful with ZBH, check out our full research report (it’s free).

Two Mid-Cap Stocks to Watch:

Leonardo DRS (DRS)

Market Cap: $11.62 billion

Developing submarine detection systems for the U.S. Navy, Leonardo DRS (NASDAQ: DRS) is a provider of defense systems, electronics, and military support services.

Why Is DRS on Our Radar?

  1. Average backlog growth of 54.4% over the past two years shows it has a steady sales pipeline that will drive future orders
  2. Additional sales over the last two years increased its profitability as the 17.5% annual growth in its earnings per share outpaced its revenue
  3. Free cash flow margin expanded by 4.7 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends

Leonardo DRS is trading at $44.99 per share, or 40.1x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.

RB Global (RBA)

Market Cap: $19.76 billion

Born from the 1958 founding of Ritchie Bros. Auctioneers and rebranded in 2023, RB Global (NYSE: RBA) operates global marketplaces that connect buyers and sellers of commercial assets, vehicles, and equipment across multiple industries.

Why Do We Like RBA?

  1. Annual revenue growth of 52.9% over the past two years was outstanding, reflecting market share gains this cycle
  2. Adjusted operating margin profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
  3. Earnings growth has massively outpaced its peers over the last five years as its EPS has compounded at 20.6% annually

RB Global’s stock price of $106.72 implies a valuation ratio of 28.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

More News

View More
Newmont's Financial Strength Sets a High Bar for Gold Miners
Today 7:18 EDT
Via MarketBeat
Tickers NEM
Golden Cross Alert: 3 Stocks With Serious Upside Potential
July 31, 2025
Via MarketBeat
Tickers CSX DDOG GOOGL
Big Beat, Bigger Plans: AEP Stock Powers Up on Data Center Boom
July 31, 2025
Via MarketBeat
Tickers AEP
UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale
July 31, 2025
Via MarketBeat
Topics Economy
Tickers T UPS VZ WBA
Why Byrna Could Be the Top Defense Stock to Watch Now
July 31, 2025
Via MarketBeat
Topics ETFs
Tickers AMZN BYRN SHLD
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap